Trial Profile
Comparison of vaccination routes: subcutaneous versus intramuscular application of FSME-Immun
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary) ; Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis
- Focus Pharmacodynamics
- Acronyms FSME-RV-IM/SC
- 11 Oct 2012 New trial record